| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2523-125 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate |
2007-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2009-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2009535050-A |
| titleOfInvention |
New fetal markers for prenatal diagnosis and monitoring |
| abstract |
The present application provides the use of novel fetal markers for prenatal diagnosis and monitoring of certain pregnancy-related conditions. More specifically, the present invention finds that certain CpG islands located on fetal chromosome 21 reveal a methylation profile that is distinguished from that of the corresponding CpG island located on maternal chromosome 21. Belonging to. The application also provides kits for diagnosing or monitoring related conditions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10731214-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10240198-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013517789-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019216734-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019176867-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016537990-A |
| priorityDate |
2006-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |